Podcast on the Diuretic Comparison Project

The filtrate discuss chlorthalidone versus hydrochlorothiazide with the study author.

Listen

PROTECT study on Sparsentan in IgAN - Visual Abstract

Is Sparsentan effective and safe for patients with IgAN on maximal Raas blockade? Check out the VA by NSMC intern Saumya Vishnoi

View fullsize

Be excited, no need to APOLogize

Huge news in APOL1 nephropathy - ten tweets to fill you in here:

Welcome to #TenTweetNephJC

✳️10 tweets #NephJC catch-up ✳️

On 4/25-26, we discussed the phase II study examining inaxaplin treatment, a small molecule inhibitor, in APOL1 nephropathy. This is the first drug specifically targeting this disease.

Join us here for the recap! pic.twitter.com/LApAHkYn10

— Nephrology Journal Club (@NephJC) May 12, 2023

The RITAZAREM visual abstract

Is Rituximab better than azathioprine for maintenance therapy of relapse in ANCA-associated vasculitis? Checkout the RITAZAREM study VA.

View fullsize

Gathering no moss

Thiazides to prevent rolling stones - the Ten Tweet summary of NOSTONE is here.

Welcome to #TenTweetNephJC - we’re again covering a practice changing trial, but unfortunately one that shows a treatment we’ve prescribed for decades for kidney stone prevention ain’t doing a huge amount....🧵 pic.twitter.com/j23gn9grw1

— Nephrology Journal Club (@NephJC) May 3, 2023